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CASE REPORT
Central retinal vein occlusion 
concomitant with dengue fever
Punithamalar Velaitham*  and Nandini Vijayasingham
Abstract 
Background: Dengue virus infection is on the rise and there is increasing number of ocular complications that are 
being reported. Most common ocular complications are macular edema, macular hemorrhages, and foveolitis. There 
are case reports on branch retinal vessel occlusions. Most of the ocular complications are attributed to the bleed-
ing tendency and transudative process in dengue viral infection. This is a case report of ischemic central retinal vein 
occlusion (CRVO) concomitant with dengue fever.
Case presentation: A 41 year old Malay female was admitted to medical ward and diagnosed to have “dengue fever 
with warning signs”. On the day of admission she noted sudden onset of right eye blurring of vision. She presented 
to our clinic 1 week later. Ocular examination revealed right eye visual acuity of <20/1000 and ischaemic CRVO with 
macular edema. She had no other risk factors to develop retinal vein occlusion. She progressively developed prolifera-
tive retinopathy and received multiple laser therapy. There was no anterior segment neovascularization. However, her 
vision improved to only 20/400 despite of resolution of macular edema and new vessels elsewhere.
Conclusion: Dengue virus infection is known to cause thrombocytopenia which can result in hemorrhagic events. 
It can also cause procoagulant state which can result in thrombotic events secondary to immune reaction. Aware-
ness among treating physicians of such ocular complication which can result in significant morbidity for patient is 
necessary.
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Background
Dengue is one of the most important arthropod-borne 
viral diseases in terms of human morbidity and mortal-
ity [1]. The number of reported dengue viral infections in 
Malaysia is alarming and on the rise [2]. Pathogenesis of 
severe dengue illness is attributed to increased vascular 
permeability and excessive bleeding caused by throm-
bocytopenia. There is an increasing evidence suggesting 
that abnormalities in the coagulation and fibrinolytic 
systems are also involved in dengue pathogenesis. Ocu-
lar complications following dengue fever include retinal 
hemorrhage, macular edema, retinal vasculitis and uvei-
tis [3]. We report a case of central retinal vein occlusion 
(CRVO) in dengue fever.
Case report
A 41  year old Malay female with no prior medical ill-
ness, was admitted to medical ward with the complain 
of fever, headache and reducing platelet and increasing 
hematocrit for 3  days duration. Her Dengue NS-1 anti-
gen was reactive which confirms dengue virus infection. 
She was diagnosed to have ‘dengue fever with warning 
signs’ based on WHO classification of levels of severity 
[1]. On admission she complained of right eye blurring of 
vision for 1 day. Fundus examination was done by medi-
cal officer in Medical ward and was documented normal. 
Therefore she was not referred to Ophthalmology depart-
ment during the hospital stay. She was treated with fluid 
resuscitation and was discharged after 5 days. However, 
right eye blurring of vision persisted and then she was 
referred to the ophthalmologist. She presented to our eye 
clinic with right eye blurring of vision for 8 days. It was 
sudden in onset and non-progressive.
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On examination, patient was alert, comfortable and 
vital signs were stable. Ocular examination noted best 
corrected visual acuity in right eye was <20/1000 and left 
eye was 20/25. Intraocular pressure was normal in both 
eyes. Relative pupillary afferent defect was detected in 
the right eye. Right eye fundus showed typical features of 
CRVO—dilated, tortuous retinal veins and retinal hem-
orrhages in all four quadrants, optic disc swelling, cotton 
wool spots and macular edema. Left eye examination was 
normal (Fig. 1).
Optical coherence tomography (OCT) of right eye 
macula disclosed cystoid spaces with edema, retinal 
thickening and subretinal fluid (Fig. 2).
Further assessment to identify the risk factors for 
CRVO were done. She was not on any hormonal con-
traception. Blood investigations were done namely fast-
ing serum lipid, fasting blood sugar, renal profile, full 
blood count (post recovery), anti-cardiolipin antibodies 
(ACA), Anti-Beta-2-Glycoprotein 1 (2GP1), Protein C 
activity, Protein S activity, Antithrombin activity, Acti-
vated Protein C Pathway which were normal. Serum elec-
trophoresis shows no paraprotein band and no immune 
paresis. Her full blood count (FBC) trend during hospital 
stay showed increasing hematocrit and reducing plate-
let which peaked on day 6 of illness and then gradually 
improved (Table  1). Her symptoms onset was during 
Fig. 1 Optic disc centred both eye fundus pictures. a Right eye—note the dilated tortuous veins, retinal hemorrhages, optic disc edema, and cot-
ton wool spots around the disc. b Left eye—normal fundus
Fig. 2 OCT of right eye macula. Note the retinal thickening, cystoid spaces within retina, and subretinal fluid
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early period of the illness when her hematocrit and plate-
let levels were still acceptable.
Six weeks later, fundus fluorescein angiography was 
done and there was delayed venous filling, less than ten 
disc diameter area of capillary dropout and areas of mask-
ing by retinal hemorrhages (Fig  3). Patient was planned 
for repeat FFA, however her right eye progress to develop 
proliferative retinopathy—new vessels elsewhere on the 
posterior pole which was treated with panretinal photo-
coagulation. There was no new vessels on the iris or angle 
noted. The macular edema improved drastically and was 
monitored with OCT imaging. Unfortunately, her vision 
did not improve. Her best corrected visual acuity of right 
eye is 20/400 and left eye 20/25.
Discussion
Ophthalmic complications following dengue fever are not 
uncommon. The spectrum of ophthalmic manifestations 
would lead one to conclude that several pathophysiologic 
processes are involved [3], namely thrombocytopenia, 
increased vascular permeability and inflammation. These 
changes manifest as anterior uveitis, retinal hemorrhage 
[4, 5], periphlebitis and macular edema [6, 7].
In this case, the thrombotic event may be related to 
immune response and down regulation of antithrombin. 
There are two different mechanisms described for this. 
Cabello et  al. described that there is downregulation of 
cytoprotective protein C pathway in human endothelial 
vascular cells in Dengue infection. Profound endothelial 
damage caused by anti–NS1 antibody cross reaction with 
vascular endothelium result in reduction of thrombo-
modulin on endothelial surface [8]. This in turn reduces 
activated protein C (APC) generation. Downregulation 
of APC anticoagulant pathway promotes thrombosis 
[8]. Conversely, Mairuhu et al. measured plasma level of 
plasminogen activator inhibitor type 1 (PAI-1) concen-
trations in patients who were admitted with clinically 
suspected severe dengue virus infection. They demon-
strated an increase in PAI-1 plasma level in individuals 
with dengue virus infection and in particular in those 
with poor clinical outcome. Primary role of PAI-1 is to 
inhibit fibrinolytic activity in  vivo [9]. These factors 
attribute to the procoagulant state and are associated 
with greater risk for thrombosis [8].
Similarly, several major vessel thrombotic events 
were reported during dengue infection in Brazil. These 
patients account for 5.4  % of all dengue inpatients. 
Severe dehydration, a well known condition associated 
with thrombotic events, was not detected in any of these 
patients. Likewise, thrombotic events in these patients 
were thought to be due to loss of endothelial non-throm-
bogenic protective factors early in the course of the dis-
ease [10].
In this case the onset of symptoms did not coincide 
with highest hemoconcentration state or lowest plate-
let level. It occurred early in the disease process which 
would suggest that immune reaction could be the cause 
of thrombosis. The most common ocular manifestation 
of dengue virus infection is macular edema, macular 
hemorrhage and foveolitis [11]. Retinal hemorrhages are 
common and can be associated with cotton wool spots. 
In this patient, cotton wool spots were numerous and 
around peridisc region. This is in keeping with CRVO 
and reflects the severity of retinal ischemia. As a conse-
quences this patient developed proliferative retinopathy 
Table 1 Full blood count results during hospital stay
The result on day 3 during which the symptoms started. It occured early in the 
disease onset. There is progressive reduction in hemotocrit and platelet level 
with peak on day 6 of illness which later gradully improves
HB hemoglobin, HCT hematocrit, PLT platelet, WBC white blood cell
Fig. 3 Fundus fluorescein angiography of right eye a shows delayed 
venous filling, b less than ten disc diameters of capillary dropout and 
masking
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which is seen in 9 % of CRVO patients within 6 months 
from onset [12]. Early commencement of laser therapy 
could have reduced vascular endothelial growth fac-
tor level in the vitreous and prevented anterior segment 
neovascularization.
This patient was treated with panretinal photocoagula-
tion for proliferative retinopathy. Intravitreal anti-vascu-
lar endothelial growth factor (anti-VEGF) injection is the 
preferred modality of treatment in some countries [13]. 
However, in our setting it is yet to be approved for the 
use in macular edema secondary to CRVO. The macular 
edema improved drastically within 2 months which was 
confirmed with OCT imaging and her vision improved 
from <20/1000 to 20/400.
Conclusion
To our best knowledge, this is the first case report of 
ischemic CRVO in Dengue fever. This adds to the evi-
dence that Dengue fever has an immunologic compo-
nent in its pathogenesis. Future study is warranted to 
ascertain if immunosuppressive therapy is beneficial 
in such patients. Attending doctors should be aware of 
diverse ophthalmic complications of dengue fever and 
co-manage with ophthalmologist to prevent and reduce 
morbidity.
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